Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Cross Above 50 Day Moving Average – Should You Sell?

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $10.86 and traded as high as $12.75. Ono Pharmaceutical shares last traded at $12.75, with a volume of 464 shares trading hands.

Ono Pharmaceutical Stock Performance

The company has a quick ratio of 2.80, a current ratio of 3.55 and a debt-to-equity ratio of 0.14. The firm has a 50-day moving average of $10.86 and a 200 day moving average of $10.89. The stock has a market capitalization of $5.99 billion, a P/E ratio of 12.26 and a beta of 0.57.

Ono Pharmaceutical (OTCMKTS:OPHLF) last released its quarterly earnings data on Monday, February 3rd. The company reported $0.21 EPS for the quarter. Ono Pharmaceutical had a net margin of 15.15% and a return on equity of 9.10%.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.